Literature DB >> 15025418

Successful treatment of metastatic esthesioneuroblastoma.

F Y F L de Vos1, P H B Willemse, E G E de Vries.   

Abstract

This case report describes a patient with a metastasised olfactorial esthesioneuroblastoma Hyams grade 4 who has been treated with debulking surgery and radiotherapy. After relapse in lymph node, lung and brain, he received additional irradiation and six cycles of carboplatin, vincristine and cyclophosphamide intravenously every three weeks. The patient has now been disease free for 7.8 years. Our data suggest that metastatic esthesioneuroblastoma is sensitive to platinum-based chemotherapy. This patient illustrates that this tumour is very sensitive to platinum-based chemotherapy and that durable complete response can be achieved, even in a metastatic ENB.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15025418

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  3 in total

1.  Esthesioneuroblastoma: endonasal endoscopic treatment.

Authors:  Paolo G Castelnuovo; Giovanni Delù; Federica Sberze; Andrea Pistochini; Cristhian Cambria; Paolo Battaglia; Maurizio Bignami
Journal:  Skull Base       Date:  2006-02

2.  Lutetium 177-DOTA-TATE therapy for esthesioneuroblastoma: A case report.

Authors:  Juliano Guerra Sabongi; Mônica Carboni Pereira Gonçalves; Cira Danielle Casado Alves; João Alves; Cristovam Scapulatempo-Neto; Sonia Marta Moriguchi
Journal:  Exp Ther Med       Date:  2016-09-20       Impact factor: 2.447

3.  Vertebral column metastases from an esthesioneuroblastoma: chemotherapy, radiation, and resection for recurrence with 15-year followup.

Authors:  Ali S Shirzadi; Doniel G Drazin; Allison S Strickland; Serguei I Bannykh; J Patrick Johnson
Journal:  Case Rep Surg       Date:  2013-02-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.